Evidence map›Paper›PMID 15083261›Full record

ArticlePsychopharmacology2004

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Paul D Arnold, David R Rosenberg, Emanuela Mundo, Subi Tharmalingam, James L Kennedy, Margaret A Richter

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05015595 (Memantine for Refractory OCD Patients), which is not on this map. Cited by 76 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 2 pooled it
11.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05015595 phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Memantine for Refractory OCD Patients: a Pragmatic Double Blind, Randomized, Parallel Group, Placebo Controlled, Monocentric Trial

TypeinterventionalSponsorUniversity of Roma La SapienzaRan2021 to 2022Enrolled20ConditionsObsessive-Compulsive DisorderArmsMemantine Oral Tablet, Placebo
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 2 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neurocognitive Endophenotypes of OCD.Current topics in behavioral neurosciences · 2021
    Article
  18. Article
  19. Review
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Paul D ArnoldChild Psychiatry Program, Neurogenetics Section, 1st Floor, Centre for Addiction and Mental Health, University of Toronto, 250 College Street, Toronto, Ontario, Canada M5T 1R8. paul_arnold@camh.net
David R Rosenberg
Emanuela Mundo
Subi Tharmalingam
James L Kennedy
Margaret A Richter
University of Toronto · CACentre for Addiction and Mental Health · CAChildren's Hospital of Michigan · US

Funding

Multimodal Investigation of Excitatory/Inhibitory Imbalances and Network Dysfunction Related to Motor Control in OCD Youth: ¹H fMRS and fMRI ApplicationsR01MH059299 · NIMH · WAYNE STATE UNIVERSITY · PI DIWADKAR, VAIBHAV A., ROSENBERG, DAVID R · 1999 to 2025
$11.1M
PEDIATRIC OBSESSIVE COMPULSIVE DISORDERK24MH002037 · NIMH · WAYNE STATE UNIVERSITY · PI ROSENBERG, DAVID R · 2001 to 2010
$1.5M
Brain Chemistry and Treatment Response in Pediatric MDDR01MH065122 · NIMH · WAYNE STATE UNIVERSITY · PI ROSENBERG, DAVID R · 2001 to 2005
$1.5M
NIMH NIH HHS K24 MH 02037NIMH NIH HHS R01 MH 065122NIMH NIH HHS R01 MH 59299
6 · The paper itself

Abstract

rationaleRecent investigation suggests that a reversible glutamatergically mediated thalamocortical-striatal dysfunction may serve as a reliable pathophysiological and treatment response marker for obsessive-compulsive disorder (OCD). We postulated that N-methyl- d-aspartate (NMDA) receptors were involved in OCD, and specifically that polymorphisms in the 3' untranslated region of GRIN2B (glutamate receptor, ionotropic, N-methyl- d-aspartate 2B) were associated with OCD in affected families.

objectivesThe objective of this investigation was to test the association between GRIN2B variants and transmission of the OCD trait using a family-based design.

methodsUsing the Family Based Association Test (FBAT), we tested for association with OCD diagnosis in 130 families, and also performed a haplotype analysis. FBAT was additionally used in a subset of 98 families to test for association with the quantitative phenotype of lifetime OCD symptom severity. RESULTS. Under a non-additive model of inheritance, the 5072T/G variant was significantly associated with OCD even after correcting for the number of models tested ( P=0.014). In addition, there was a significant positive association with OCD diagnosis ( P=0.002) for the 5072G-5988T haplotype under the recessive model.

conclusionsAlthough preliminary and requiring replication in larger samples, these results provide evidence that GRIN2B may be associated with susceptibility to OCD. Coupled with basic neuroscience and clinical neuroimaging findings in patients with OCD, our results provide new and converging support for the role of altered glutamatergic neurotransmission in the pathogenesis of OCD.

Indexed as

Family HealthGenetic Variation3' Untranslated RegionsAllelesFemaleHumansLinkage DisequilibriumMaleObsessive-Compulsive DisorderPolymorphism, GeneticPsychiatric Status Rating ScalesReceptors, N-Methyl-D-AspartateReverse Transcriptase Polymerase Chain ReactionRNA, Messenger3' Untranslated RegionsNR2B NMDA receptorReceptors, N-Methyl-D-AspartateRNA, Messenger

Identifiers

PMID15083261
OpenAlexW1998622616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.